期刊文献+

亚砷酸治疗急性早幼粒细胞白血病的临床观察 被引量:2

下载PDF
导出
摘要 目的 观察亚砷酸治疗急性早幼粒细胞白血病 (APL)的临床疗效。方法 初治、复发、难治APL患者 36例 ,采用亚砷酸为主的治疗方案 ,观察其治疗效果和不良反应。结果 初治APL的完全缓解率为 81.8% ,总有效率为 90 .0 % ;难治性APL的完全缓解率为 5 7.1% ,总有效率 85 .7% ;高白细胞综合征发生率占 6 7% ,其他不良反应较轻。结论 亚砷酸治疗急性早幼粒细胞白血病有效安全 ,对复发 /难治病例有较好疗效。
出处 《重庆医学》 CAS CSCD 2004年第9期1399-1400,共2页 Chongqing medicine
  • 相关文献

参考文献3

二级参考文献4

共引文献321

同被引文献16

  • 1Chen SJ, Chen Z,Chen A, et al. Occurrence of distinctPML-RAR-alpha fusion gene isoforms in patients with a-cute promyelocytic leukemia detected by reverse tran-scriptase/ polymerase chain reaction[J]. Oncogene,1992,7(6):1223-1232.
  • 2Wang ZY, Chen Z. Acute promyelocytic leukemia: fromhighly fatal to highly curable[J], Blood, 2008, 111 (5):2505-2515.
  • 3Jurcic JG,Nimer SD,Scheinberg DA,et al. Prognostic sig-nificance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acutepromyelocytic leukemia [J]. Blood. 2001,98 ( 9 ) : 2651-2656.
  • 4Beillard E,Pallisgaard N,van der Velden VH,et al. Eval-uation of candidate control genes for diagnosis and residu-al disease detection in leukemic patients using ' real-time'quantitative reverse-transcriptase polymerase chain reac-tion (RQ-PCR)-a Europe against Cancer program [ Jj.Leukemia,2003,17(12) :2474-2486.
  • 5Cheson BD, Bennett JM, Kopecky KJ,et al. Revised rec-ommendations of the International Working Group for Di-agnosis ,Standardization of Response Criteria, TreatmentOutcomes,and Reporting Standards for Therapeutic Tri-als in Acute Myeloid Leukemia[J]. J Clin Oncol, 2003 .21(24):4642-4649.
  • 6Barragan E, Montesinos P, Camos M, et al. Prognosticvalue of FLT3 mutations in patients (下转第 3387 页)(上接第3384页)with acute promyelocytic leukemia treated with all-transretinoic acid and anthracycline monochemotherapy [ J].Haematologica,2011,96(10) : 1470-1477.
  • 7Mathews V,Thomas M, Srivastava VM,et al. Impact ofFLT3 mutations and secondary cytogenetic changes onthe outcome of patients with newly diagnosed acute pro-myelocytic leukemia treated with a single agent arsenictrioxide regimen [J]. Haematologica, 2007,92 ( 7 ) : 994-995.
  • 8Slack JL, Yu M. Constitutive expression of the promyelo-cytic leukemia-associated oncogene PML-RARalpha inTF1 cells: isoform-specific and retinoic acid-dependenteffects on growth,bcl-2 expression, and apoptosis [J].Blood,1998,91(9):3347-3356.
  • 9Hu J. Arsenic in the treatment of newly diagnosed acutepromyelocytic leukemia: current status and future re-search direction[J]. Front Med,2011,5(1) *45-52.
  • 10Lengfelder E,Hofmann WK,Nowak D. Impact of Arsenictrioxide in the treatment of acute promyelocytic leukemia[J]. Leukemia,2012,26(3) :433-442.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部